Grayhawk Investment Strategies Inc. Takes $762,000 Position in Molina Healthcare, Inc. (NYSE:MOH)

Grayhawk Investment Strategies Inc. bought a new stake in Molina Healthcare, Inc. (NYSE:MOH) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 2,110 shares of the company’s stock, valued at approximately $762,000.

A number of other institutional investors and hedge funds also recently modified their holdings of MOH. Keybank National Association OH bought a new stake in shares of Molina Healthcare in the 3rd quarter valued at about $373,000. Janney Montgomery Scott LLC grew its stake in Molina Healthcare by 17.6% in the 3rd quarter. Janney Montgomery Scott LLC now owns 3,005 shares of the company’s stock valued at $986,000 after buying an additional 450 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Molina Healthcare by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 345,766 shares of the company’s stock valued at $113,373,000 after buying an additional 4,126 shares during the last quarter. Van ECK Associates Corp grew its stake in Molina Healthcare by 34.3% in the 3rd quarter. Van ECK Associates Corp now owns 11,251 shares of the company’s stock valued at $3,689,000 after buying an additional 2,871 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC grew its stake in Molina Healthcare by 35.3% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 5,602 shares of the company’s stock valued at $1,837,000 after buying an additional 1,462 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Truist Financial upped their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. Bank of America lowered shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price target on the stock. in a research note on Thursday, March 28th. Wells Fargo & Company decreased their price target on shares of Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. Finally, Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $407.45.

Molina Healthcare Price Performance

NYSE:MOH traded down $3.84 during mid-day trading on Friday, reaching $309.56. The stock had a trading volume of 449,950 shares, compared to its average volume of 519,138. The stock has a 50-day simple moving average of $348.66 and a two-hundred day simple moving average of $369.29. The stock has a market capitalization of $18.14 billion, a PE ratio of 16.80, a P/E/G ratio of 0.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. Molina Healthcare, Inc. has a 12 month low of $269.67 and a 12 month high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The business had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. During the same period last year, the firm posted $5.81 earnings per share. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year. On average, equities analysts anticipate that Molina Healthcare, Inc. will post 23.56 earnings per share for the current year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the sale, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the sale, the chief operating officer now owns 53,613 shares in the company, valued at $18,504,526.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronna Romney sold 250 shares of Molina Healthcare stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the transaction, the director now owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.